Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 28 , ISSUE 7 ( July, 2024 ) > List of Articles

Original Article

Diagnostic Potential of Serum Interleukin-6 in Predicting Bacteremia in Adult Patients with Sepsis: A Prospective Observational Study

Penna RV Reddy, Mounika Cherukuri, Vandana K Eshwara, Chandrashekar Udyavara Kudru, RV Krishnananda Prabhu

Keywords : Bacteremia, Interleukin-6, Mortality, Sepsis, Septic shock

Citation Information : Reddy PR, Cherukuri M, Eshwara VK, Kudru CU, Prabhu RK. Diagnostic Potential of Serum Interleukin-6 in Predicting Bacteremia in Adult Patients with Sepsis: A Prospective Observational Study. Indian J Crit Care Med 2024; 28 (7):637-644.

DOI: 10.5005/jp-journals-10071-24754

License: CC BY-NC 4.0

Published Online: 29-06-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Background: This study aimed to assess the potential of serum interleukin-6 (IL-6) as a diagnostic marker in predicting bacteremia and to determine its association with severity and outcome among sepsis patients. Materials and methods: A prospective observational study was conducted, comprising a cohort of 118 patients admitted to the ICU with suspected sepsis from January 2019 to April 2020. Results: Among the 108 patients analyzed, 60 (55.6%) were bacteremic and 48 (44.4%) were nonbacteremic. Of 60 patients with bacteremia, 13 (21.6%) had sepsis and 47 (78.3%) had septic shock. In predicting bacteremia, the area under the curve (AUC) for IL-6 was 0.512 [95% CI, 0.400–0.623]. The AUC for IL-6 in differentiating sepsis from septic shock was 0.724 [95% CI, 0.625–0.823]. The sensitivity and specificity for predicting bacteremia for IL-6 were 66% and 67%, respectively (p < 0.001). Multivariate analysis revealed that C-reactive protein (CRP) (p = 0.04) and APACHE II score (p = 0.025) were significant predictors of bacteremia, whereas lactate (p = 0.04), and APACHE II score (p < 0.001) were significant predictors of sepsis severity. Patients with elevated levels of procalcitonin PCT (p = 0.024), APACHE II (p = 0.003), and SOFA (p = 0.002) scores had significantly higher mortality rates. Conclusion: C-reactive protein and APACHE II score, lactate and APACHE II score, and PCT, SOFA, and APACHE II scores performed better in predicting bacteremia, sepsis severity, and clinical outcome, respectively compared with IL-6.

PDF Share
  1. Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, et al. International Forum of Acute Care Trialists. Assessment of global incidence and mortality of hospital-treated sepsis. current estimates and limitations. Am J Respir Crit Care Med 2016;193(3):259–272. DOI: 10.1164/rccm.201504-0781OC.
  2. Singer M, Deutschman CS, Seymour CW, Shnkar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;315(8):801–810. DOI: 10.1001/jama.2016.0287.
  3. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 2017;43(3):304–377. DOI: 10.1007/s00134-017-4683-6.
  4. Vazquez-Grande G, Kumar A. Optimizing antimicrobial therapy of sepsis and septic shock: Focus on antibiotic combination therapy. Semin Respir Crit Care Med 2015;36:154–166. DOI: 10.1055/s-0034-1398742.
  5. Molano Franco D, Arevalo-Rodriguez I, Roqué I Figuls M, Zamora J. Interleukin-6 for diagnosis of sepsis in critically ill adult patients. Cochrane Database of Syst Rev 2015;7:CD011811. DOI: 10.1002/14651858.
  6. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis; A systematic review and meta-analysis. Lancet Infect Dis 2013;13(5):426–435. DOI: 10.1016/S1473-3099(12)70323-7.
  7. Dahaba AA, Metzler H. Procalcitonin's role in the sepsis cascade. Is procalcitonin a sepsis marker or mediator? Minerva Anestesiol 2009;75:447–452. Corpus ID: 39501458.
  8. Wu Y, Wang M, Zhu Y, Lin S. Serum interleukin-6 in the diagnosis of bacterial infection in cirrhotic patients: A meta-analysis. Medicine (Baltimore) 2016;95(41):e5127. DOI: 10.1097/MD.0000000000005127.
  9. Lin S, Huang Z, Wang M, Weng Z, Zeng D, Zhang Y, et al. Interleukin-6 as an early diagnostic marker for bacterial sepsis in patients with liver cirrhosis. J Crit Care 2015;30:732–738. DOI: 10.1016/j.jcrc.2015.03.031.
  10. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease Classification system. Crit Care Med 1985;13(10):818–829. DOI: 10.1097/00003465-198603000-00013.
  11. von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, Lehmann L, Breig P, Hahn C, et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: Procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis 2004;23(7):539–544. DOI: 10.1590/S1807-59322011001000006.
  12. Kumari N, Dwarakanath BS, Das A, Bhatt AN. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol 2016;37(9):11553-11572. DOI: 10.1007/s13277-016-5098-7.
  13. Sahbudak Bal Z, Karadaş Özdemir N, Şen S, Yılmaz Karapınar D, Azarsız E, Aydemir Ş, et al. Diagnostic accuracy of interleukin-6, interleukin-8, and interleukin-10 for predicting bacteremia in children with febrile neutropenia. Turk J Haematol 2017;34(3):254–257. DOI: 10.4274/tjh.2016.0434.
  14. Urbonas V, Eidukaitė A, Tamulienė I. The diagnostic value of interleukin-6 and interleukin-8 for early prediction of bacteremia and sepsis in children with febrile neutropenia and cancer. J Pediatr Hematol Oncol 2012;34(2):122–127. DOI: 10.1097/MPH.0b013e3182446a60.
  15. Demirdal T, Sen P, Nemli SA. Diagnostic value of procalcitonin in predicting bacteremia in intensive care unit. Indian J Crit Care Med 2018;22(2):78–84. DOI: 10.4103/ijccm.IJCCM_437_17.
  16. Diepold M, Noellke P, Duffner U, Kontny U, Berner R. Performance of Interleukin-6 and Interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk. BMC Infect Dis 2008;8:28. DOI: 10.1186/1471-2334-8-28.
  17. Desai S, Lakhani JD. Utility of SOFA and APACHE II score in sepsis in rural set up MICU. J Assoc Physicians India 2013;61(9):608–611.
  18. Takahasi W, Nakada TA, Yazaki M, Oda S. Interleukin-6 levels act as a diagnostic marker in patients with organ dysfunction in intensive care units. Shock 2016;46(3):254–260. DOI: 10.1097/SHK.00000 00000000616.
  19. Behnes M, Bertsch T, Lepiorz D, Lang S, Trinkmann F, Brueckmann M, et al. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. Crit Care 2014;18(5):507. DOI: 10.1186/s13054-014-0507-z.
  20. Song J, Park DW, Moon S, Cho HJ, Park JH, Seok H, et al. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: A prospective controlled study according to the Sepsis-3 definitions. BMC Infect Dis 2019;19(1):968. DOI: 10.1186/s12879-019-4618-7.
  21. Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother 2011;66(Suppl 2): ii33–40. DOI: 10.1093/jac/dkq523.
  22. Gaïni S, Koldkjaer OG, Pedersen C, Pedersen SS. Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: A prospective study. Crit Care 2006;10(2):R53. DOI: 10.1186/cc4866.
  23. Jekarl DW, Lee SY, Lee J, Park YJ, Kim Y, Park JH, et al. Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis. Diagn Microbiol Infect Dis 2013;75(4):342–347. DOI: 10.1016/j.diagmicrobio.2012.12.011.
  24. Miguel-Bayarri V, Casanoves-Laparra EB, Pallás-Beneyto L, Sancho-Chinesta S, Martín-Osorio LF, Tormo-Calandín C, et al. Prognostic value of the biomarkers procalcitonin, interleukin-6 and C-reactive protein in severe sepsis. Med Intensiva 2012;36(8):556–562. DOI: 10.1016/j.medin.2012.01.014.
  25. Mustafić S, Brkić S, Prnjavorac B, Sinanović A, Porobić Jahić H, Salkić S. Diagnostic and prognostic value of procalcitonin in patients with sepsis. Med Glas (Zenica) 2018;15(2):93–100. DOI: 10.17392/963-18.
  26. Gao L, Yang B, Zhang H, Ou Q, Lin Y, Zhang M, et al. DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin. Oncotarget 2017;9(13):10934–10944. DOI: 10.18632/oncotarget.23736.
  27. Yu H, Qi Z, Hang C, Fang Y, Shao R, Li C. Evaluating the value of dynamic procalcitonin and presepsin measurements for patients with severe sepsis. Am J Emerg Med 2017;35(6):835–841. DOI: 10.1016/j.ajem.2017.01.037.
  28. Charles PE, Noel R, Massin F, Guy J, Bollaert PE, Quenot JP, et al. Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with sepsis. BMC Infect Dis 2016;16(1):559. DOI: 10.1186/s12879-016-1893-4.
  29. Gotts JE, Matthay MA. Sepsis: Pathophysiology and clinical management. BMJ 2016;343:1585. DOI: 10.1136/bmj.i1585.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.